Home
Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals... Market Share Analysis for May 2026

lundbeck group corporate website

Health > Biotechnology and Pharmaceuticals

Domainalderbio.com

Year Founded2004

Employees201 - 500

Annual Revenue$5M - $10M

Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals, Inc. (including company regionals)

alderbio.com

See more website traffic and engagement information

Alder BioPharmaceuticals, Inc. Revenue up to May 2026 is 5M - 10M

revenue generated by Alder BioPharmaceuticals, Inc. top domains

Alder BioPharmaceuticals, Inc. top domains revenue over 3 years

Revenue for Alder BioPharmaceuticals, Inc. top domains

alderbio.com5M - 10M

See more with Sales Intelligence

Total visits to Alder BioPharmaceuticals, Inc.'s top domains

Understand Alder BioPharmaceuticals, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Alder BioPharmaceuticals, Inc.'s top domains

Analyze Alder BioPharmaceuticals, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Alder BioPharmaceuticals, Inc.'s top domains

See how Alder BioPharmaceuticals, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Alder BioPharmaceuticals, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

arenapharm.comCompany NameArena Pharmaceuticals, Inc.Employees201 - 500HQUnited States, California, San DiegoAnnual revenue> $1BTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Alder BioPharmaceuticals, Inc.

These are the website technologies, by industry, used by Alder BioPharmaceuticals, Inc. top domains

Widget (4)

Twemoji

Conversion & Analytics (2)

Google Analytics

Marketing (2)

Google Marketing Platform

Social (2)

Facebook Connect

More Technologies

8

See all

News & Signals from Alder BioPharmaceuticals, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlderbio is developing ALD1910.About ALD1910 Alder is developing ALD1910, an investigational monoclonal antibody (mAb) designed to inhibit pituitary adenylate cyclase-activating polypeptide (PACAP) for migraine prevention.

NewsAlderbio is developing eptinezumab-an investigational monoclonal antibody.Alder is developing eptinezumab-an investigational monoclonal antibody (mAb) that is administered as a quarterly 30-minute IV infusion-for the preventive treatment of migraine in adults.

NewsLundbeck Group acquired Alderbio for $1.95B on Jan 1st '19.Lundbeck, a publicly traded pharmaceutical developer, has agreed to acquire Seattle-area biotech company Alder BioPharmaceuticals for €1.8 billion (about $1.98 billion).